Verona Gets $400M Boost from Oxford Finance, Hercules Capital for COPD Candidate

cafead

Administrator
Staff member
  • cafead   Jan 03, 2024 at 10:12: AM
via Verona Pharma, a biotech working on treating chronic obstructive pulmonary disease, has been given a financial boost of up to $400 million from two capital firms, the company announced Tuesday.

article source
 

<